Expanding U.S. BioPharma to Europe: Strategies for Success

This by-invitation-only event will bring together a select group of life sciences executives to discuss best practices and strategies for U.S. companies looking to successfully expand into the European market. Among our esteemed guest speakers, we are delighted to include executives from Blueprint Medicines, who have successfully established operations across Europe and brought forward a rare disease medicine through the complex European market access and pricing environment.  Besides the access & pricing challenges, we will also touch on some HR topics like timelines of hiring, and competitiveness of the market for top talents. Our speakers will share their valuable experiences and insights, while also engaging in an open debate about the opportunities available for U.S. biotech companies aiming to establish a presence in Europe.

Expanding U.S. BioPharma to Europe: Strategies for Success_Header


Georg Pirmin Meyer, Blueprint Medicines

Georg Pirmin Meyer, SVP Head of International, Blueprint Medicines

Ulf Staginnus, Blueprint Medicines

Ulf Staginnus, VP International Market Acces & Pricing, Blueprint Medicines

Olivier Schiltz Korn Ferry Portrait

Oliver Schiltz, Managing Director, Korn Ferry Switzerland

Thomas Fuchs, Kt Zug

Thomas Fuchs, Deputy Head Economic Promotion, Canton of Zug

Moderation by

Lukas Sieber, Portrait rund

Lukas Sieber, Executive Director North America, Greater Zurich Area Ltd.


More about Greater Zurich as a life science hub

Do you want to be close to major players, innovative start-ups and leading research institutes in the life sciences space? The Greater Zurich Area has evolved into a dynamically expanding life sciences hotspot, thanks to the region’s academic excellence, business-friendly regulations, IP protection, large international talent pool and R&D collaborations between universities and start-ups, as well as large multinational corporations.

Want to write your own success story?

Contact us

Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?